Home/Filings/4/0001804831-24-000001
4//SEC Filing

Bonnell Brian Michael 4

Accession 0001804831-24-000001

CIK 0000883984other

Filed

Mar 10, 8:00 PM ET

Accepted

Mar 11, 4:28 PM ET

Size

24.0 KB

Accession

0001804831-24-000001

Insider Transaction Report

Form 4
Period: 2024-03-07
Bonnell Brian Michael
Chief Financial Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2024-03-08+2,21021,408 total
  • Tax Payment

    Common Stock

    2024-03-08$104.52/sh3,998$417,87123,487 total
  • Exercise/Conversion

    Common Stock

    2024-03-072,1452,146 total
    Exercise: $0.00From: 2023-03-07Exp: 2025-03-07Common Stock (2,145 underlying)
  • Tax Payment

    Common Stock

    2024-03-08$104.52/sh1,212$126,67820,196 total
  • Exercise/Conversion

    Common Stock

    2024-03-08+7,28927,485 total
  • Exercise/Conversion

    Performance Shares

    2024-03-087,2890 total
    Exercise: $0.00Exp: 2024-03-08Common Stock (7,289 underlying)
  • Exercise/Conversion

    Common Stock

    2024-03-07+2,14514,560 total
  • Tax Payment

    Common Stock

    2024-03-07$105.39/sh7,059$743,94819,198 total
  • Exercise/Conversion

    Common Stock

    2024-03-082,2100 total
    Exercise: $0.00From: 2023-03-08Exp: 2024-03-08Common Stock (2,210 underlying)
  • Tax Payment

    Common Stock

    2024-03-07$105.39/sh1,175$123,83313,385 total
  • Exercise/Conversion

    Common Stock

    2024-03-07+12,87226,257 total
  • Exercise/Conversion

    Performance Shares

    2024-03-0712,8720 total
    Exercise: $0.00Exp: 2024-03-07Common Stock (12,872 underlying)
Footnotes (8)
  • [F1]These securities are Restricted Stock Units.
  • [F2]These Securities are Performance-based Restricted Stock Units (PRSU).
  • [F3]There is neither a purchase price nor an exercise price for the Restricted Stock Units.
  • [F4]One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date.
  • [F5]These are restricted stock units that fully vest 3 years from the grant date.
  • [F6]There is neither a purchase price nor an exercise price for the PRSUs.
  • [F7]These PRSUs were granted on March 7, 2022 and had a 2-year cliff-vest performance period subject to the satisfaction of performance-based metrics and continuous services through the vest date. The PRSUs were approved for vesting in February 2024 by the Compensation Committee at 200% of the original grant.
  • [F8]These PRSUs were granted on March 8, 2021 and had a 3-Year cliff-vest subject to the satisfaction of performance-based metrics and continuous services through the vest date. The PRSUs were approved for vesting in February 2024 by the Compensation Committee at 110% of the original grant.

Issuer

ICU MEDICAL INC/DE

CIK 0000883984

Entity typeother

Related Parties

1
  • filerCIK 0001804831

Filing Metadata

Form type
4
Filed
Mar 10, 8:00 PM ET
Accepted
Mar 11, 4:28 PM ET
Size
24.0 KB